Festive Fraud

Two biomedical researchers have been found guilty of falsifying data.

Written byDan Cossins
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, STEAKPINBALLFederal investigators ended 2012 by censuring two researchers for scientific misconduct. In a Federal Register notice published last week (26 December), the Office of Research Integrity (ORI) announced that Terry S. Elton, who studies the role of messenger RNA in cardiovascular disease at Ohio State University, had falsified or fabricated Western blots—a technique used to identify proteins—in a National Institutes of Health grant and in 18 figures included in six different published papers. As a result of the investigation, Elton agreed to exclude himself from federal grant applications for 3 years and requested the retraction of five papers.

Two days later (28 December 2012), the ORI announced that Martin Biosse-Duplan of the Harvard School of Dental Medicine falsified data in a lab meeting and two published abstracts. Biosse-Duplan, who studies the cellular basis of bone formation and resorption, agreed to exclude himself from federal grant applications for 2 years. For another 2 years after that period, his research will be supervised by the ORI to ensure scientific integrity.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies